Conmed (CNMD) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 215.00 |
| Dec 31, 2025 | 215.00 |
| Sep 30, 2025 | 273.00 |
| Jun 30, 2025 | 597.00 |
| Mar 31, 2025 | 395.00 |
| Dec 31, 2024 | 484.00 |
| Sep 30, 2024 | 499.00 |
| Jun 30, 2024 | 379.00 |
| Mar 31, 2024 | 245.00 |
| Dec 31, 2023 | 11.00 |
| Sep 30, 2023 | -217.00 |
| Jun 30, 2023 | -277.00 |
| Mar 31, 2023 | -255.00 |
| Dec 31, 2022 | -37.00 |
| Sep 30, 2022 | 248.00 |
| Jun 30, 2022 | 336.00 |
| Mar 31, 2022 | 443.00 |
| Dec 31, 2021 | 392.00 |
| Sep 30, 2021 | 306.00 |
| Jun 30, 2021 | 326.00 |
| Mar 31, 2021 | -53.00 |
| Dec 31, 2020 | -228.00 |
| Sep 30, 2020 | -248.00 |
| Jun 30, 2020 | -182.00 |
| Mar 31, 2020 | 29.00 |
| Dec 31, 2019 | -33.00 |
| Sep 30, 2019 | -46.00 |
| Jun 30, 2019 | -169.00 |
| Mar 31, 2019 | -123.00 |
| Dec 31, 2018 | 13.00 |
| Sep 30, 2018 | -11.00 |
| Jun 30, 2018 | -39.00 |
| Mar 31, 2018 | -93.00 |
| Dec 31, 2017 | -292.00 |
| Sep 30, 2017 | 232.00 |
| Jun 30, 2017 | 216.00 |
| Mar 31, 2017 | 167.00 |
| Dec 31, 2016 | 211.00 |
| Sep 30, 2016 | -516.00 |